These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 32097987)

  • 21. THE SPECTRUM OF TP53, SF3B1, AND NOTCH1 MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS EXPOSED TO IONIZING RADIATION DUE TO THE CHORNOBYL NPP ACCIDENT.
    Bilous NI; Abramenko IV; Chumak AA; Dyagil IS; Martina ZV; Saenko V; Bazyka DA
    Probl Radiac Med Radiobiol; 2018 Dec; 23():283-301. PubMed ID: 30582853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NOTCH1 and SF3B1 mutations can be added to the hierarchical prognostic classification in chronic lymphocytic leukemia.
    Mansouri L; Cahill N; Gunnarsson R; Smedby KE; Tjönnfjord E; Hjalgrim H; Juliusson G; Geisler C; Rosenquist R
    Leukemia; 2013 Feb; 27(2):512-4. PubMed ID: 23138133
    [No Abstract]   [Full Text] [Related]  

  • 23. Patients with chronic lymphocytic leukemia with mutated VH genes presenting with Binet stage B or C form a subgroup with a poor outcome.
    Tobin G; Thunberg U; Laurell A; Karlsson K; Aleskog A; Willander K; Söderberg O; Merup M; Vilpo J; Hultdin M; Sundström C; Roos G; Rosenquist R
    Haematologica; 2005 Apr; 90(4):465-9. PubMed ID: 15820941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL.
    Sportoletti P; Baldoni S; Cavalli L; Del Papa B; Bonifacio E; Ciurnelli R; Bell AS; Di Tommaso A; Rosati E; Crescenzi B; Mecucci C; Screpanti I; Marconi P; Martelli MF; Di Ianni M; Falzetti F
    Br J Haematol; 2010 Nov; 151(4):404-6. PubMed ID: 20813007
    [No Abstract]   [Full Text] [Related]  

  • 25. Common nonmutational
    Fabbri G; Holmes AB; Viganotti M; Scuoppo C; Belver L; Herranz D; Yan XJ; Kieso Y; Rossi D; Gaidano G; Chiorazzi N; Ferrando AA; Dalla-Favera R
    Proc Natl Acad Sci U S A; 2017 Apr; 114(14):E2911-E2919. PubMed ID: 28314854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics of chronic lymphocytic leukemia with somatically acquired mutations in NOTCH1 exon 34.
    Shedden K; Li Y; Ouillette P; Malek SN
    Leukemia; 2012 May; 26(5):1108-10. PubMed ID: 22182918
    [No Abstract]   [Full Text] [Related]  

  • 27. NOTCH1 mutations in chronic lymphocytic leukemia with trisomy 12.
    Orlandi EM; Rossi M
    Genes Chromosomes Cancer; 2012 Nov; 51(11):1063; author reply 1064-5. PubMed ID: 22833497
    [No Abstract]   [Full Text] [Related]  

  • 28. Insulin growth factor 1 receptor expression is associated with NOTCH1 mutation, trisomy 12 and aggressive clinical course in chronic lymphocytic leukaemia.
    Maura F; Mosca L; Fabris S; Cutrona G; Matis S; Lionetti M; Agnelli L; Barbieri M; D'Anca M; Manzoni M; Colombo M; Massucco C; Reverberi D; Gentile M; Recchia AG; Bossio S; Ilariucci F; Musolino C; Di Raimondo F; Cortelezzi A; Morabito F; Ferrarini M; Neri A
    PLoS One; 2015; 10(3):e0118801. PubMed ID: 25786252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance of c.7544-7545 delCT NOTCH1 mutation in chronic lymphocytic leukaemia.
    Del Poeta G; Dal Bo M; Del Principe MI; Pozzo F; Rossi FM; Zucchetto A; Bomben R; Degan M; Rasi S; Rossi D; Bulian P; Gaidano G; Amadori S; Gattei V
    Br J Haematol; 2013 Feb; 160(3):415-8. PubMed ID: 23167503
    [No Abstract]   [Full Text] [Related]  

  • 30. [Chronic lymphocytic leukemia: diagnosis and gene mutations].
    Aoki S
    Rinsho Ketsueki; 2014 Oct; 55(10):1981-8. PubMed ID: 25297763
    [No Abstract]   [Full Text] [Related]  

  • 31. NOTCH1 mutations are associated with high CD49d expression in chronic lymphocytic leukemia: link between the NOTCH1 and the NF-κB pathways.
    Benedetti D; Tissino E; Pozzo F; Bittolo T; Caldana C; Perini C; Martorelli D; Bravin V; D'Agaro T; Rossi FM; Bomben R; Santinelli E; Zaja F; Pozzato G; Chiarenza A; Di Raimondo F; Del Poeta G; Rossi D; Gaidano G; Dal Bo M; Gattei V; Zucchetto A
    Leukemia; 2018 Mar; 32(3):654-662. PubMed ID: 28935990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NOTCH1, SF3B1, BIRC3 and TP53 mutations in patients with chronic lymphocytic leukemia undergoing first-line treatment: correlation with biological parameters and response to treatment.
    Chiaretti S; Marinelli M; Del Giudice I; Bonina S; Piciocchi A; Messina M; Vignetti M; Rossi D; Di Maio V; Mauro FR; Guarini A; Gaidano G; Foà R
    Leuk Lymphoma; 2014 Dec; 55(12):2785-92. PubMed ID: 24597984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia.
    Baldoni S; Del Papa B; Dorillo E; Aureli P; De Falco F; Rompietti C; Sorcini D; Varasano E; Cecchini D; Zei T; Di Tommaso A; Rosati E; Alexe G; Roti G; Stegmaier K; Di Ianni M; Falzetti F; Sportoletti P
    Int J Cancer; 2018 Aug; 143(4):958-970. PubMed ID: 29508386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted next-generation sequencing in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation in a clinical setting.
    Sutton LA; Ljungström V; Mansouri L; Young E; Cortese D; Navrkalova V; Malcikova J; Muggen AF; Trbusek M; Panagiotidis P; Davi F; Belessi C; Langerak AW; Ghia P; Pospisilova S; Stamatopoulos K; Rosenquist R
    Haematologica; 2015 Mar; 100(3):370-6. PubMed ID: 25480502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2.
    Strefford JC; Sutton LA; Baliakas P; Agathangelidis A; Malčíková J; Plevova K; Scarfó L; Davis Z; Stalika E; Cortese D; Cahill N; Pedersen LB; di Celle PF; Tzenou T; Geisler C; Panagiotidis P; Langerak AW; Chiorazzi N; Pospisilova S; Oscier D; Davi F; Belessi C; Mansouri L; Ghia P; Stamatopoulos K; Rosenquist R
    Leukemia; 2013 Nov; 27(11):2196-9. PubMed ID: 23558524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 14q deletions are associated with trisomy 12, NOTCH1 mutations and unmutated IGHV genes in chronic lymphocytic leukemia and small lymphocytic lymphoma.
    Cosson A; Chapiro E; Belhouachi N; Cung HA; Keren B; Damm F; Algrin C; Lefebvre C; Fert-Ferrer S; Luquet I; Gachard N; Mugneret F; Terre C; Collonge-Rame MA; Michaux L; Rafdord-Weiss I; Talmant P; Veronese L; Nadal N; Struski S; Barin C; Helias C; Lafage M; Lippert E; Auger N; Eclache V; Roos-Weil D; Leblond V; Settegrana C; Maloum K; Davi F; Merle-Beral H; Lesty C; Nguyen-Khac F;
    Genes Chromosomes Cancer; 2014 Aug; 53(8):657-66. PubMed ID: 24729385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel NOTCH1 PEST domain mutation in a case of chronic lymphocytic leukemia.
    Sportoletti P; Baldoni S; Del Papa B; Cantaffa R; Ciurnelli R; Aureli P; Rosati E; Marconi P; Di Ianni M; Falzetti F
    Leuk Lymphoma; 2013 Aug; 54(8):1780-2. PubMed ID: 23151304
    [No Abstract]   [Full Text] [Related]  

  • 38. Diminished interaction between mutant NOTCH1 and the NuRD corepressor complex upregulates CCL17 in chronic lymphocytic leukemia.
    Wang S; Ge M; Cui J; Qiao Z; Chen X; Wu S; Zhan R; Zhou H; Liu H; Xu Z
    Leukemia; 2019 Dec; 33(12):2951-2956. PubMed ID: 31341237
    [No Abstract]   [Full Text] [Related]  

  • 39. Mutations in NOTCH1 PEST domain orchestrate CCL19-driven homing of chronic lymphocytic leukemia cells by modulating the tumor suppressor gene DUSP22.
    Arruga F; Gizdic B; Bologna C; Cignetto S; Buonincontri R; Serra S; Vaisitti T; Gizzi K; Vitale N; Garaffo G; Mereu E; Diop F; Neri F; Incarnato D; Coscia M; Allan J; Piva R; Oliviero S; Furman RR; Rossi D; Gaidano G; Deaglio S
    Leukemia; 2017 Sep; 31(9):1882-1893. PubMed ID: 28017968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. lncRNA profiling in early-stage chronic lymphocytic leukemia identifies transcriptional fingerprints with relevance in clinical outcome.
    Ronchetti D; Manzoni M; Agnelli L; Vinci C; Fabris S; Cutrona G; Matis S; Colombo M; Galletti S; Taiana E; Recchia AG; Bossio S; Gentile M; Musolino C; Di Raimondo F; Grilli A; Bicciato S; Cortelezzi A; Tassone P; Morabito F; Ferrarini M; Neri A
    Blood Cancer J; 2016 Sep; 6(9):e468. PubMed ID: 27611921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.